The misconceptions about cannabis began in the 1930s caused a massive stigma for the plant-based drug. This stigma is still present now, especially in the population that makes up those generations. Seniors want to try marijuana for pain, but the misconceptions of past prevent them from relieve of today. The American Medical Association acknowledges medical marijuana can help patients.
At least 40% of Americans who are above the age of 65 are suffering from several types of pain. Some experience it for a short while, while others have long-term pain.
For seniors above the age of 80, about 75% suffer from chronic pain, especially the ones in assisted living quarters like nursing homes.
Photo by rawpixel.com
Many patients are manage conditions like hip and knee pain, insomnia, cancer, and other tough conditions. Some are also recuperating after major surgeries and are in long term pain. Analgesics do little to relieve pain after continuous use, and people have certainly used the drugs continuously over their long rich lives.
It’s time seniors, as well as their guardians and caregivers, come to terms with the therapeutic benefits from cannabis plants.
Senior Citizens and Cannabis Stigma
When cannabis prohibitions began in the 1930s, the seniors of today were just children. From the onset of their lives, they had it ingrained in them that cannabis was an evil of society. This continued till the mid-1900s when they also instilled the same messages in their children.
The government portrayed cannabis as an ill of society which shouldn’t be condoned, and to these seniors, it has remained an evil of society.
Yes, they may have heard the news about the decriminalization of cannabis in their state of residence, but they still consider it an illegal substance. In a survey carried out by Gallup some weeks ago, less than 19% of Americans above the age of 75 say they have tried using cannabis at some point in their lives. This is how low the acceptance of the drug is among that group.
For the children born in the ’60s, many have taken steps to register in medical marijuana programs. Quite a few of these “grandfolks” bring up topics about marijuana discreetly, as though they feel they are still breaking the law.
The cannabis stigma is worse in senior Americans who are also persons of color. They went through traumatizing episodes due to the War on Drugs and have been left at a disadvantage since then. For most of these seniors, their minds have been conditioned that cannabis use is followed by destruction.
American Seniors Deserve More
Nobody — young or old — deserves to suffer from chronic pain, Especially when effective medical cannabis drugs have been approved for treating such conditions.
Older adults who deserve to have every comfort at this last stage of their lives are conditioned by their experience many years ago to remain silent, even in an epidemic of chronic pain.
Photo by Tim Robberts/Getty Images
Aging itself comes with varying degrees of aches and pains, and all these are compounded by social isolation, insomnia, dementia, disability, and even depression. The current data of senior adults refusing medical marijuana treatment is bothersome. As they choose to remain in pain instead of seeking relief.
Addressing the Crisis
Had it been that these older adults could tolerate NSAIDs, the silent crisis may not have been as serious as this. Drugs like acetaminophen, naproxen, and ibuprofen have intense aftereffects on the body organs of senior citizens. Many who can withstand opioids have managed with it. However, opioids are not sufficient enough to resolve the problem, not to mention the high risk of addiction involved.
Now is the right time for medical marijuana programs to pass on information to the senior generation about the benefits of plant-based medicines like cannabis. Caregivers should also be taught about the non-addictive nature of cannabinoids.
At this present time, medical obstacles such as these should not be a thing. The fear-mongering and propaganda these American seniors were subjected to back then are seriously holding them back from accessing what they need the most.
The federal prohibition of cannabis Is one of the factors that make these older people believe that cannabis consumption is likely to harm them. It seals their life-long belief that cannabis remains a threat to public safety. These old folks can’t be blamed for being wary of plant-based medication because of what they’ve been programmed to believe.
Photo by Tyler Farmer via Unsplash
Hillary Lum, a pediatrician and associate professor at the University of Colorado School of Medicine, said that many of these senior citizens are fearful, and sometimes ashamed whenever they ask about cannabis. In a survey carried out by Lum, and published in 2019, “30% of older adults didn’t answer the question about whether or not they used medical marijuana,” said Lum. “If people feel uncomfortable with it on an anonymous survey, they may also feel uncomfortable telling their doctor. That could have ramifications for their health.”
Older Americans can first be introduced to the wonders of CBD instead of cannabis. Many may show interest in trying CBD to manage their symptoms. Health departments have to make informed medical counsels available at all times for these residents. Safety assurance and access to the drug also have to be made stress-free to encourage these seniors to opt into the treatment.
More Cannabis Research
Medical personnel occasionally lay complaints about being unable to recommend cannabis drugs due to the minimal clinical research carried out in the field.
Even in states that have legalized the medical use of cannabis, doctors have not been fully briefed about the impacts and risks of cannabis use. Due to this, most of these doctors refuse to prescribe medical cannabis to patients suffering from serious conditions.
An example is Texas. The state has over 43,000 doctors and only 150 are registered members of the medical cannabis program. There’s no easy way an uninformed doctor would be able to convince a senior citizen that plant-based drugs can serve as effective treatments.
Federal decriminalization of cannabis will be the most effective way to convince senior citizens and their caregivers that cannabis is their best choice to get relief. Health care providers, journalists, celebrities, family members, caregivers, and older Americans have to speak up about the benefits of cannabis as a reliable pain reliever for Americans. This could incentivize governments to bring barriers down.
Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.
The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster. With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes. Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.
The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.
During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.
The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.
The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.
While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.
States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.
The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.
“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”
Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds. Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.
States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.
In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.
Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.
The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.
This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.
The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.
The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses. Millions use medical marijuana for health issues ranging from chronic pain to sleep. But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.
The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.
Photo by yavdat/Getty Images
The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.
Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.
In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.
This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.